diagnost anim health
blood analyz blood test veterinarian
client offer wide rang chemistri
hematolog immunotherapi test
high-definit digit radiographi
digit ultrasound technolog pair
requir disclosur end report
report tough expect stock like
end risk event print reiter neutral
view current cl king meet event calendar coverag univers
expect report tough miss top line initi
guidanc street expect said compani initi
realist guidanc remain optimist product launch could help
acceler revenu satisfi expect reset howev
still get comfort growth acceler thesi
done admir job go market share
compani longer obscur player
anim health space face player see
competit threat reiter neutral rate
skinni quarter although post revenu
guidanc wors even bear case think
overhang stock approach risk event miss
well-telegraph lack buyer event
rebas growth provid room upsid think
investor grab thu understand move
guidanc conserv lap comp
base growth compani inde would impli
mid-teen normal forward growth rate one assum
stack growth rate asid imag
product grew revenu busi model alon
compani believ new product geograph expans would
new product geograph initi expect updat
investor growth initi upcom analyst day may
new york includ new product geograph expans
although direct involv potenti larg neg impact
 wed welcom move longer term put growth
profit
high throughput analyz launch high
throughput chemistri analyz wvc tradit high
throughput analyz havent done well market think alfa
wassermann modest traction model exact
opposit competitor approach alfa wassermann sell
analyz charg penni consum wherea
wouldnt surpris see give away analyz free
charg premium consum
revenu report revenu versu
year-ago period year year still miss
lower estim street
companion segment post revenu versu
estim year year
ep guidanc ep versu last year
strip non-cash tax charg post ep
beat street estim
respect compani initi guidanc revenu growth
impli revenu versu recent lower
street
annual number post annual revenu
versu year year ep
versu year ago adjust one-tim tax benefit
unusu tax rate post ep versu
model lower revenu estim
actual rais ep forecast
base delay spend lower tax rate increas
 expens ad rep off-set lower cost
delay european expans also decreas
revenu project modestli
rais ep estim also base
risk includ relianc distributor regul multipl sole supplier
vet industri macro situat price concess competit addit
think abaxi abaxa could get acquir zoeti
elanco part nr
page
